XML 55 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data)Year Ended December 31,
202320222021
Numerator      
Net increase (decrease) in net assets resulting from operations$337,484 $102,081 $174,155 
Less: Total distributions declared(278,301)(249,077)(179,575)
Total Earnings, net of total distributions59,183 (146,996)(5,420)
      
Earnings, net of distributions attributable to common shares58,593 (146,995)(5,420)
Add: Distributions declared attributable to common shares275,548 246,873 177,864 
Numerator for basic and diluted change in net assets per common share$334,141 $99,878 $172,444 
      
Denominator      
Basic weighted average common shares outstanding144,091 125,189 114,742 
Incremental shares from assumed conversion of 2022 Convertible Notes— — 512 
Common shares issuable735 1,470 701 
Weighted average common shares outstanding assuming dilution144,826 126,659 115,955 
Change in net assets per common share:
Basic$2.32 $0.80 $1.50 
Diluted$2.31 $0.79 $1.49 
Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock For the years ended December 31, 2023, 2022 and 2021, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
 Year Ended December 31,
Anti-dilutive Securities202320222021
Unvested common stock options1,4962,085690
Restricted stock units*4,35720
Unvested restricted stock awards30,0282,116861
*Included in these amounts are shares related to certain equity-based awards, which are fully vested but have not been delivered and thus not outstanding for purposes of calculating earnings per share.